Reaction #155329
ord-64f1f98f6e324a17a8329873ce2fb169
Reaction equation
Reactants
Reagents
Solvents
Conditions
Workup
- 1Concentrationconcentrated under reduced pressure
- 2workup.ADDITIONWater and ethyl acetate were added to the residue
- 3Otherfollowed by separation
- 4WashThe thus-obtained organic layer was washed with water
- 5Concentrationconcentrated under reduced pressure
- 6OtherThe residue was purified
- 7ConcentrationThe purified product was concentrated under reduced pressure
- 8Otherthe residue was recrystallized from ethyl acetate
Procedure
4-(2-Aminoethyl)morpholine (217 mg, 1.7 mmol) was added to a DMF solution (10 ml) of [3-(4-methoxyphenyl)-4-oxo-10-propoxy-7,8-dihydro-4H,6H-5-oxa-1-aza-phenanthren-1-yl]acetic acid (580 mg, 1.39 mmol), 2-(7-aza-1H-benzotriazol-1-yl)-1,1,3,3-tetramethyl uronium hexafluorophosphate (HATU, 790 mg, 2.1 mmol) and triethylamine (5 ml). The mixture was stirred overnight at room temperature and then concentrated under reduced pressure. Water and ethyl acetate were added to the residue, followed by separation. The thus-obtained organic layer was washed with water and concentrated under reduced pressure. The residue was purified using silica gel column chromatography (dichloromethane:methanol=10:1). The purified product was concentrated under reduced pressure, and the residue was recrystallized from ethyl acetate, giving a pale brown powder of 2-[3-(4-methoxyphenyl)-4-oxo-10-propoxy-7,8-dihydro-4H,6H-5-oxa-1-aza-phenanthren-1-yl]-N-(2-morpholin-4-ylethyl)acetamide (115 mg, yield: 16%).